Monoclonal antibody-drug conjugateFDA-approvedSecond-line
Ado-trastuzumab emtansine
How it works
Delivers a toxic payload to HER2-positive cancer cells, killing them and preventing further growth.
Cancer types
Breast Cancer— HER2-positive
Efficacy
Studies have shown that ado-trastuzumab emtansine can improve progression-free survival and overall survival in patients with HER2-positive breast cancer who have received prior therapy.
Side effects
Severe
This treatment carries a higher risk of serious side effects. Close medical monitoring is required throughout treatment.
This information is provided for general education only and is not medical advice. Always consult a qualified healthcare professional before making treatment decisions.